132 related articles for article (PubMed ID: 6287707)
1. [Safety of foot-and-mouth disease vaccines in cell cultures].
Tekerlekov P; Dilovski M; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(1):21-5. PubMed ID: 6287707
[TBL] [Abstract][Full Text] [Related]
2. [Methods of testing of safety of the anti-foot-and-mouth disease vaccine].
Dannacher G; Fédida M; Coudert M; Perrin M
Dev Biol Stand; 1976; 35():271-8. PubMed ID: 198294
[TBL] [Abstract][Full Text] [Related]
3. [The role of foot-and-mouth disease antibodies of sera in BHK 21 industrial cell cultures used for the production of vaccines].
Mammerickx M; Leunen J
Bull Off Int Epizoot; 1968; 69(3):487-96. PubMed ID: 4303694
[No Abstract] [Full Text] [Related]
4. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
Bauer K
Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
[TBL] [Abstract][Full Text] [Related]
5. [Comparative testing of the quality of foot-and-mouth disease vaccines prepared with different virus inactivators].
Dilovski M; Tekerlekov P
Vet Med Nauki; 1983; 20(5-6):41-5. PubMed ID: 6318423
[TBL] [Abstract][Full Text] [Related]
6. Some problems of testing foot-and-mouth disease vaccines. I. Innocuity testing.
Soós T
Acta Vet Hung; 1987; 35(3):319-30. PubMed ID: 2829601
[No Abstract] [Full Text] [Related]
7. Investigations on the suitability of mice for potency testing of FMD vaccines.
Bernhardt D; Runge W; Restle H
Dev Biol Stand; 1976; 35():285-8. PubMed ID: 198296
[TBL] [Abstract][Full Text] [Related]
8. [Combined method (suspension-monolayer) of preparing an inactivated foot-and-mouth disease vaccine].
Genov I; Tivchev G; Veleva E; Tekerlekov P; Shopov I
Vet Med Nauki; 1981; 18(5):57-63. PubMed ID: 6275604
[TBL] [Abstract][Full Text] [Related]
9. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
[No Abstract] [Full Text] [Related]
10. [Immunobiological properties of strains of foot-and-mouth disease virus multiplying in cell cultures].
Efimov NI; Siusiukin AA; Shvetsova RV; Serodzhev AT
Veterinariia; 1975 May; (5):53-5. PubMed ID: 174272
[No Abstract] [Full Text] [Related]
11. Quantification, characterisation and safety testing of foot-and-mouth disease virus antigens eluted from alhydrogel vaccines.
Visser N; Woortmeyer R
Dev Biol Stand; 1981; 50():277-83. PubMed ID: 6176487
[TBL] [Abstract][Full Text] [Related]
12. Innocuity testing of foot-and-mouth disease vaccines. II. Aziridine-inactivated antigen produced in baby hamster kidney cells.
Barteling SJ
J Biol Stand; 1983 Oct; 11(4):305-12. PubMed ID: 6315737
[TBL] [Abstract][Full Text] [Related]
13. [Allergic reactions in cattle vaccinated against foot-and-mouth disease with vaccines prepared from viruses cultivated in BHK cells in roller bottles].
Pappous C; Verbelis P
Dev Biol Stand; 1976; 35():97-101. PubMed ID: 198319
[TBL] [Abstract][Full Text] [Related]
14. [Laboratory trials of culturing BHK 21 C 13 cells in a roller using an enzymatic egg hydrolysate-based nutrient medium].
Veleva E; Genov I; Stefanova L; Tekerlekov P; Tivchev G
Vet Med Nauki; 1980; 17(9-10):37-42. PubMed ID: 6266126
[TBL] [Abstract][Full Text] [Related]
15. [Several criteria of evaluation of foot-and-mouth disease virus reproduced in cell cultures in suspension].
Girard HC
Dev Biol Stand; 1976; 35():91-6. PubMed ID: 71255
[TBL] [Abstract][Full Text] [Related]
16. [Immunogenic properties of foot-and-mouth vaccines].
Tekerlekov P; Nikolova E; Dilovski M
Vet Med Nauki; 1983; 20(5-6):46-51. PubMed ID: 6318424
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of viruses multiplying in cell lines in suspension and their correspondent vaccines].
Roulet C; Favre H; Mougeot H; Brun A; Fargeaud D; Dubouclard C
Dev Biol Stand; 1976; 35():79-90. PubMed ID: 198317
[TBL] [Abstract][Full Text] [Related]
18. [Anti-foot-and-mouth vaccines combined with other bacterial or viral vaccines].
Favre H; Valette L; Précausta P; Roulet C; Brun A; Terré J; Fontaine J; Stellmann C
Dev Biol Stand; 1976; 35():409-28. PubMed ID: 198309
[TBL] [Abstract][Full Text] [Related]
19. The suitability of a rolled BHK21 monolayer system for the production of vaccines against the SAT types of foot-and-mouth disease virus. I. Adaptation of virus isolates to the system, immunogen yields achieved and assessment of subtype cross reactivity.
Esterhuysen JJ; Thomson GR; Ashford WA; Lentz DW; Gainaru MD; Sayer AJ; Meredith CD; Janse van Rensburg D; Pini A
Onderstepoort J Vet Res; 1988 Jun; 55(2):77-84. PubMed ID: 2839810
[TBL] [Abstract][Full Text] [Related]
20. The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period.
Radlett PJ; Pay TW; Garland AJ
Dev Biol Stand; 1985; 60():163-70. PubMed ID: 2995169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
